FDA stopped foreign inspections due to COVID-19

In response to the COVID-19 outbreak, the FDA is postponing most foreign inspections through April outside of the US due to travel restrictions. The FDA has confidence in its ability to maintain oversight over international manufacturers and imported products using alternative tools and methods, including monitoring products at the border, review of importer compliance, and sharing of information with foreign governments. The FDA, through its risk-based import screening tool (PREDICT), will focus examinations and sample collections based on heightened concerns of specific products being entered into US commerce. @ https://www.fda.gov/news-events/press-announcements/coronavirus-disease-2019-covid-19-update-foreign-inspections?utm_campaign=031020_PR_Coronavirus%20%28COVID-19%29%20Update%3A%20Foreign%20Inspections&utm_medium=email&utm_source=Eloqua